Slaughter and May is advising global healthcare company GlaxoSmithKline (GSK) on a £650m move to increase its stake in its India and Nigeria subsidiaries.

The magic circle firm is has put forward a team under corporate partners David Johnson, Simon Nicholls and Richard Smith to advise GSK.